patients

Consistent exercise linked to reduced phenotypic age acceleration, highlighting the importance of tailored physical activity for healthy aging in type 2 diabetes. Study: Dose response of leisure time physical activity and…
Read More...

Source link : News-Medica
Read More...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast…
Read More...

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They have less protein in their urine, less inflammation in their kidneys and lower blood…
Read More...

if (g_displayableSlots.mobileTopLeaderboard) { pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); }); } Syngap Research FundOct 30 2024 The SynGAP Research Fund 501(c)(3) has…
Read More...

Physical activity of any intensity after a diagnosis of dementia is associated with around a 30% lower risk of death, finds research published online in the British Journal of Sports Medicine. The findings prompt the…
Read More...

Following a low-carb diet may potentially help patients manage disease more effectively and reduce medication use. Study: Effects of a Carbohydrate-Restricted Diet on β-Cell Response in Adults With Type 2 Diabetes. Image…
Read More...

if (g_displayableSlots.mobileTopLeaderboard) { pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); }); } Amsterdam University Medical CenterOct 25 2024 A single treatment with, a…
Read More...

Aerobic exercise during chemotherapy boosts self-reported cognitive function and quality of life in breast cancer patients, but objective improvements remain elusive, study finds. Study: Aerobic exercise and CogniTIVe…
Read More...

Prescriptions of GLP-1RAs and SGLT2 inhibitors in type 1 diabetes patients rose from 2010 to 2023, especially among those with elevated cardiorenal risk. Study: GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in…
Read More...